Dr. Jeffrey Apter participated at Global Site Solutions Summit in Florida this weekend
Last week, the 2017 Global Site Solutions Summit opened its doors to professionals of clinical trials industry. The Summit pursued the objective to engage industry leaders from CROs, Pharma companies, study sites and regulatory authorities in a dynamic dialogue and allowed them to directly interact with each other.
Every year brings new inventions, discoveries and advanced solutions to facilitate and improve sites’ operations and procedures. This year’s topics include enrollment issues, clinical data collection and management at all levels, inspections and many others. Site partnership symposiums were focused on promoting knowledge and mobilizing insight into study pipeline opportunities and site sustainability.
Operating globally in 8 countries, GCT is a CRO that gained an impressive background of successfully completed studies in CNS, gastroenterology, oncology, ophthalmology, reproductive health and rare diseases. GCT President Dr. Jeffrey Apter, a Principal Investigator of over 100 trials in Depression, Anxiety, Bipolar Disorder, Schizophrenia and Alzheimer’s Disease, is closely aware of issues that sites come across in their everyday activities. Please contact email@example.com to schedule a face-to-face meeting with Dr. Apter at the next event to share best practices and discuss your clinical development plans.